Develops cell therapies for cancer treatments.
Dec 2025Revenue $22.0K/yrExpenses $68.8M/yr
No trendCash runway ≈ 2 months from Jun 2026
Figures by year
When will Senti Biosciences Holdings be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $22.0K and expenses $68.8M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $22.0K | $68.8M | −$68.8M |
| Dec 2024 | $0.00 | $61.0M | −$61.0M |
| Dec 2023 | $1.98M | $94.7M | −$92.7M |
| Dec 2022 | $3.29M | $65.4M | −$62.1M |
| Dec 2021 | $2.29M | $42.7M | −$40.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.